Hillchol (BBV131) vaccine Type: Oral cholera vaccine (OCV) . Dosage: Administered in two doses ; Day 0 and Day 14. Target Group: Suitable ...
Hillchol (BBV131) vaccine
Type: Oral cholera vaccine (OCV).
Dosage: Administered in two doses; Day 0 and Day 14.
Target Group: Suitable for children older than one year.
Storage: Requires storage between 2 - 8°C
Available as single-dose respule and mono-multidose formats.
Who Developed It?
Developer: Bharat Biotech International Ltd.
Licensing: Developed under license from Hilleman Laboratories.
Funding and Collaboration: Funded by Merck (USA) and Wellcome Trust (UK).
Collaborators: Includes Hilleman Laboratories, University of Gothenburg, and Gotovax AB
COMMENTS